Sleep Apnea Devices market is one of the most common sleep complaints where there is an abnormal halt in the breathing of a person which can be for few seconds or even few minutes. According to American Sleep Association, 50-70 million US adults have some kind of sleeping disorder, among which 25 Million people are suffering from obstructive sleep apnea (OSA). Centre for Disease Control and Prevention has also found that the annual healthcare cost for OSA in the US is $165 billion which is way high than asthma and obesity. The sleep apnea devices market is resulting in reduced productivity at work and increase in road accidents. The National Highway Traffic Safety Administration has projected that about 100,000 car accidents, 40,000 injuries and 1,550 deaths occur annually due to fatigue of the drivers.
Major risk factors leading to sleep apnea are obesity, lifestyle habits such as smoking, alcohol, and substance abuse, and irregular sleep patterns. Growing incidence of sleep & respiratory disorders, increasing practice of oral appliances, technological advancements in diagnostic and therapeutic devices, and a large pool of undiagnosed sleep apnea patients are the factors driving the market for sleep apnea devices market. However, the high costs of sleep apnea devices and alternative treatment options are hampering the growth of the sleep apnea devices market.
The diagnostic and therapeutic sleep devices are the two segments considered and therapeutic devices segments are having a major market share by 2017. Lack of awareness of the diseases and stringent regulatory approval is the major challenge the growth of the market. Nasal obstruction and discomfort of the CPAP masks, and nose & mouth dryness are some of the unmet needs of sleep apnea therapeutic devices. An Oral appliance is used to address the unmet need of the CPAP devices; thus, they are slowly gaining importance in the sleep apnea devices market.
The sleep apnea devices market in North America is anticipated to grow at a swift pace during the period 2018-2024. In 2017, United States dominated the sleep apnea devices market in 2017, and it was followed by Canada. Expanding incidence of sleep apnea in the US and rising availability of grants and funding are driving the market for sleep apnea devices market in North America. Few of the prominent players in the market are ResMed, Inc., Philips Healthcare, Fisher & Paykel Healthcare Ltd, BMC Medical Co. Ltd, SomnoMed, Inc, Natus Medical Incorporated, Global Medical Holdings LLC, Itamar Medical, Ltd., and Weinmann Medical Devices GmbH & Co. KG. By end users, the huge market share is occupied by hospitals and sleep laboratories. Technological advancements in the devices are giving rise to user-friendly and compact products. These factors are making the market of home sleep study products to grow at a high rate.
The sleep apnea devices market report provides the complete details of various market trends and adoption rate in various segments and across North America. The major trends, drivers, restraints, and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the Sleep Apnea Devices market.
This sleep apnea devices market report also provides the competitive landscape of the leading players in North America Sleep Apnea Devices market and this study will help the vendors to understand their competitor’s landscape. The report can also be tailored as per the specific info required by the users. The customization of the report is available based on countries, vendor profiles, enterprise and vertical wise.
- Product Type
- Therapeutic Device
- Diagnostic Devices
- End Users
- Home Care
- Sleep Laboratories and Hospitals
- North America
- Asia Pacific
Rest of the World